These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1604362)

  • 1. Methods for quality adjustment of life years.
    Nord E
    Soc Sci Med; 1992 Mar; 34(5):559-69. PubMed ID: 1604362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest reliability of health state valuation techniques: the time trade off and person trade off.
    Robinson S
    Health Econ; 2011 Nov; 20(11):1379-91. PubMed ID: 21053203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The QALY--a measure of social value rather than individual utility?
    Nord E
    Health Econ; 1994; 3(2):89-93. PubMed ID: 8044215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of health state utilities for dentofacial deformity as derived from patients and members of the general public.
    Cunningham SJ; Hunt NP
    Eur J Orthod; 2000 Jun; 22(3):335-42. PubMed ID: 10920566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What value health?: A review of health state values used in early technology assessments for NICE.
    Stein K; Fry A; Round A; Milne R; Brazier J
    Appl Health Econ Health Policy; 2005; 4(4):219-28. PubMed ID: 16466273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized Elderly Longitudinal Project.
    Tsevat J; Dawson NV; Wu AW; Lynn J; Soukup JR; Cook EF; Vidaillet H; Phillips RS
    JAMA; 1998 Feb; 279(5):371-5. PubMed ID: 9459470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are QALYs based on time trade-off comparable?--A systematic review of TTO methodologies.
    Arnesen T; Trommald M
    Health Econ; 2005 Jan; 14(1):39-53. PubMed ID: 15386674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valuation of health-related quality of life and utilities in health economics].
    Greiner W; Klose K
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(2-3):120-5. PubMed ID: 24780709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value measurement in cost-utility analysis: explaining the discrepancy between rating scale and person trade-off elicitations.
    Ubel PA; Loewenstein G; Scanlon D; Kamlet M
    Health Policy; 1998 Jan; 43(1):33-44. PubMed ID: 10178799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roughly right or precisely wrong? Systematic review of quality-of-life weights elicited with the time trade-off method.
    Arnesen T; Trommald M
    J Health Serv Res Policy; 2004 Jan; 9(1):43-50. PubMed ID: 15006240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time trade-off utility modified to accommodate degenerative and life-threatening conditions.
    Kattan MW; Fearn PA; Miles BJ
    Proc AMIA Symp; 2001; ():304-8. PubMed ID: 11825200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing values for health: numeracy matters.
    Woloshin S; Schwartz LM; Moncur M; Gabriel S; Tosteson AN
    Med Decis Making; 2001; 21(5):382-90. PubMed ID: 11575488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The validity of time trade-off values in calculating QALYs: constant proportional time trade-off versus the proportional heuristic.
    Dolan P; Stalmeier P
    J Health Econ; 2003 May; 22(3):445-58. PubMed ID: 12683961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the measurement of health utilities in published cost-utility analyses.
    Brauer CA; Rosen AB; Greenberg D; Neumann PJ
    Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient preference quality of life measures in dermatology.
    McCombs K; Chen SC
    Dermatol Ther; 2007; 20(2):102-9. PubMed ID: 17537138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost utility analysis: what should be measured?
    Richardson J
    Soc Sci Med; 1994 Jul; 39(1):7-21. PubMed ID: 8066489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ranking properties of healthy-years equivalents and quality-adjusted life-years under certainty and uncertainty.
    Johannesson M
    Int J Technol Assess Health Care; 1995; 11(1):40-8. PubMed ID: 7706013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unchained melody: revisiting the estimation of SF-6D values.
    Craig BM
    Eur J Health Econ; 2016 Sep; 17(7):865-73. PubMed ID: 26359242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.